Skip to content

Christopher W. Swift, D.O.

NPI 1023320280ActiveIndividual· Internal Medicine, Critical Care Medicine· Meridian, MS

Internal Medicine, Critical Care Medicine (D.O.) in Meridian, Mississippi, trained at University of South Alabama College of Medicine (class of 2010). Their prescriptions cost Medicare Part D more than their services did: $1,054,078 for 11,892 claims, against $86,052 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 3 companies reporting payments in 2025, $538.95 in all, mostly food and beverage.

Overview

NPI1023320280
StatusActive
Entity typeIndividual
CredentialD.O.
Sole proprietorYes
NPI issuedJul 4, 2010
Last updated in NPPESDec 13, 2018

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Internal Medicine (AL); Practitioner - Internal Medicine (MS)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients447
Services billed1,236 across 32 procedure codes
Paid by Medicare$86,052

Part D prescriptions in 2024

Prescriptions (claims)11,892 · 21,958 30-day fills
Patients646
Total drug cost$1,054,078
Generic share85% of claims

Medicare sources and data years

Education and affiliations

Medical schoolUniversity of South Alabama College of Medicine
Graduation year2010
Medicare specialtyInternal Medicine

Medical group

Hospital affiliations

Other facilities

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$538.95 · 5 payments from 3 companies
  • 2024$25.51 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Astrazeneca Pharmaceuticals LP$311.153
Amgen Inc.$125.001
Novo Nordisk Inc$102.801

What the 2025 payments were for

  • Food and Beverage$538.95 · 5 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records